Leaderboard

En | De
No articles selected!     View Cart  
You are here: Psychiatry » Schizophrenia and Psychotic Disorders 23. June 2026
Search
medline.ch
Schizophrenia and Psychotic Disorders
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Anxiety Disorders
Dementia
Depressive Disorders
Eating Disorders
Personality Disorders
Schizophrenia and Psychotic Disorders
Sleep Disorders
Sexual Disorders
Somatoform Disorders
Substance-Related Disorders
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3457  Previews Next
   
   Articles 1 - 20 / 69122  
   
The Multisensory Hallucinations Schedule to assess hallucinations across multiple sensory modalities in psychosis: A pilot validation study.
Aust N Z J Psychiatry
Toh WL, Bell A, Bere M, Rossell SL.
PMID: 42333638 [PubMed - as supplied by publisher]


Development of Physical Activity from Childhood to Adolescence in Offspring at Familial High Risk of Schizophrenia or Bipolar Disorder and Population-Based Controls: The Danish High Risk and Resilience Study.
Schizophr Bull Open
Søndergaard A, Rohd SB, Schiavon M, Streymá DHFB, Wilms M, Gregersen M, Bundgaard AF, Laursen AF, Hemager N, Krantz MF, Hjorthøj C, Veddum L, Greve AN, Thorup AAE, Nordentoft M.
PMID: 42333288 [PubMed]


Cognitive profiles in psychosis: comparing those experiencing uni- or multisensory versus multimodal hallucinations.
Cogn Neuropsychiatry
Toh WL, Bere M, Bell A, Rossell SL.
PMID: 42332353 [PubMed - as supplied by publisher]


Co-expression-based models improve eQTL predictions for transcriptome-wide association studies and highlight new schizophrenia-associated genes.
Nat Genet
Rossi F, Sportelli L, Kikidis GC, Grassi G, Di Camillo F, Bertolino A, Blasi G, Borcuk CJ, Fusco D, Hyde TM, Kleinman JE, Marnetto D, Pellegrini S, Rampino A, Vitiello B, Ripke S, Braun A, Kraft J, Belangero SI, Menezes PR, Arango C, Walters JTR, O'Donovan MC, Owen MJ, Braff D, Corvin A, Morris DW, Domenici E, van Os J, Atba, Saka MC, Di Forti M, Baune BT, Pato CN, McQuillin A, Golimbet V, Kondratyev N, Escott-Price V, Gareeva A, Khusnutdinova E, Cervilla JA, Rivera M, Campion D, Laurent-Levinson C, Serretti A, Andreassen OA, St Clair D, Lencz T, Malhotra AK, McCarthy NS, Mowry BJ, Rujescu D, Giegling I, Hartmann AM, Konte B, Nöthen MM, Rietschel M, Kirov G, Sullivan PF, Petryshen TL, Werge T, McIntosh AM, Esko T, Jönsson EG, Ehrenreich H, Riley BP, Levinson DF, Buxbaum JD, Bramon E, Hultman CM, Ophoff RA, Adolfsson R, Stahl EA, Guloksuz S, Rutten BPF, Del-Ben CM, Thibaut F, Weinberger DR, Pergola G.
PMID: 42332269 [PubMed - as supplied by publisher]


Transdiagnostic mapping of brain structural abnormalities and network-constrained gray matter atrophy patterns across affective and psychotic disorders.
Mol Psychiatry
Qin K, Zhu P, Chen X, Sang L, Liu H, Chen H, Xiang J, Ran J, Deng X, Pan N, Ai C, DelBello MP, Singh MK, Chen W.
PMID: 42332027 [PubMed - as supplied by publisher]


Narrative exposure therapy in early intervention in psychosis services (NETp): protocol of a multi-site feasibility randomised controlled trial study .
BMJ Open
Fornells-Ambrojo M, Plaistow J, Hardy A, Martin P, Lyons N, Khan Z, Mberi A, Morris T, Johnson S.
PMID: 42331582 [PubMed - in process]


Systematic Review and Meta-Analysis: Prevalence, Correlates, and Impact of Cannabis Use and Cannabis Use Disorder in Early-Onset Psychosis.
J Am Acad Child Adolesc Psychiatry
Salazar de Pablo G, Laherran-Cantera N, Aymerich C, Galvañ J, Palacios-Garrán R, Armyra E, Pedruzo B, Lahera G, Catalán A, Díaz-Caneja CM, Calvo A, Arango C, Di Forti M, Murray RM, Correll CU.
PMID: 42331312 [PubMed - as supplied by publisher]


Inner speech and the neurobiology of psychosis.
Neurosci Biobehav Rev
Skipper JI, Lametti DR, Green DW.
PMID: 42331125 [PubMed - as supplied by publisher]


Long-term antipsychotic use and cardiometabolic adverse effects in adults with non-psychotic disorders: A systematic review.
Psychiatry Res
Radha Krishnan RP, Dzidowska M, Zheng D, Russell DJ, Rhaman A, Quintrell E, Chan CH, Buckley NA, Raubenheimer JE.
PMID: 42330864 [PubMed - as supplied by publisher]


Antipsychotic-related remodeling of regional brain activity in schizophrenia.
Asian J Psychiatr
Liang J, Chen W, Zhang C.
PMID: 42330654 [PubMed - as supplied by publisher]


Sex differences in higher-order cognition in schizophrenia and unaffected first-degree relatives: a longitudinal, family study.
Eur Arch Psychiatry Clin Neurosci
Balanzá-Martínez V, Sánchez-Ortí JV, Correa-Ghisays P, Selva-Vera G, Van Rheenen TE, Tabarés-Seisdedos R.
PMID: 42329320 [PubMed - as supplied by publisher]


The Staging Model in Psychosis and Preventive Interventions: An Emerging Field With Debates on Conceptual Models and Interpretation of the Evidence Base.
Early Interv Psychiatry
van der Gaag M, Mei C, Nelson B, Berger M, Krcmar M, Amminger GP, Bechdolf A, Hutton P, Cuijpers P, Yung AR, McGorry PD.
PMID: 42328781 [PubMed - indexed for MEDLINE]


Validation and Functional Exploration of Exosome-Derived ITGA9-AS1 and WNT5A-AS1 as Candidate Diagnostic Biomarkers for Schizophrenia.
Neuropsychiatr Dis Treat
Xu Y, Wang Y, Qin F, Yu L, Li W, You X, Guo L, Liu Y, Zeng Y.
PMID: 42327849 [PubMed]


From case-control averages to validated subgroups: Interpreting inflammatory and neuroaxonal-injury biomarkers in schizophrenia and major depression.
Brain Behav Immun Health
Guest PC, Cunningham JL, Raabe F, Schiltz K, Asl LS, Nickl-Jockschat T, Steiner J.
PMID: 42327387 [PubMed]


Expressive writing combined with digital cognitive therapy in patients with schizophrenia: a narrative review of efficacy, linguistic phenotypes, and adherence modulators.
Front Psychiatry
Wen H, Liu Y, Wang Y, Zhang Y.
PMID: 42325981 [PubMed]


Predicting functional remission after antipsychotic discontinuation: a real-world study in schizophrenia - ERRATUM.
Psychol Med
Lu C, Dong Y, Zhai Z, Gao T, Luo M, Chang D, Chen J, Xue J, Zhao Y, Xiang Q, Li X, Ma X, Wei Z, Feng T, Liu D.
PMID: 42325016 [PubMed - in process]


Baduanjin combined with computerized cognitive remediation therapy for the treatment of schizophrenia : a 8-week randomized controlled trial.
BMC Psychiatry
Xue Q, Liang W, Xiao L, Hao Q, Ma W, Zhou Z.
PMID: 42324517 [PubMed - as supplied by publisher]


Predicting relapse risk from patients' perceptions of family functioning in early psychosis: A three-year longitudinal study.
Psychiatry Res
Morejón AJV, Reyes AV, Muñoz-Caracuel MA, Vázquez-Morejón R.
PMID: 42322924 [PubMed - as supplied by publisher]


Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapine.
Psychiatry Res
Kroken RA, Johnsen E, Alisauskiene R, Anda LG, Bartz-Johannesen C, Berle JØ, Bjarke J, Bruserud Ø, Fathian F, Fleischhacker WW, Hugdahl K, Joa I, Kjelby E, Larsen TK, Løberg EM, Ratke I, Rettenbacher M, Sinkeviciute I, Skrede S, Stabell L, Steen VM, Torsvik A, Reitan SK.
PMID: 42322923 [PubMed - as supplied by publisher]


The impact of symptoms and illness insight on treatment adherence in first-episode psychosis: a one-year follow-up study using therapeutic drug monitoring.
BMC Psychiatry
Leijala J, Kampman O, Gunnar T, Suvisaari J.
PMID: 42321753 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 69122    Page 1 of 3457  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1